DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie


Eichhorst B, Fink AM, Bahlo J. et al.
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.

Lancet Oncol 2016;
17: 928-942

Download Bibliographical Data

Search in: